AI Science Tracker
EN

A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: an analysis of the SEER database.

Not stated in the abstract reviewed · 30 Jun 2025 · medicine

Discovery

A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: an analysis of the SEER database.

Source check: Source checked. Not independent scientific confirmation.

Finding: XGBoost and random forest screening informed a renal-cancer survival nomogram, while a propensity-matched SEER analysis found an observational surgery-survival association.

Technology: SEER training and validation cohorts (982 and 420 patients) were analyzed; Cox model, calibration, ROC, decision curves and matching assess results.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
SEER training and validation cohorts (982 and 420 patients) were analyzed; Cox model, calibration, ROC, decision curves and matching assess results.
Test and result
This qualifies as retrospective clinical prediction; the surgery association remains observational and potentially confounded, not causal.
Limitation / still unknown
Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1572580/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.